For example, the mechanism of the protective effect of ApoA-I on endothelial function through the inhibition of EndMT induced by TGF-β1 has been shown, which can be further used as a therapeutic target in the treatment of atherosclerosis [150]. This evidence concerns the gene TGFB1 and atherosclerosis.